NSC |
Compound |
Enrichment |
Correlation |
NSC 709900 |
Isoxazolo[5,4-d]-1,2,3-triazin-4(3H)-one, 3-(4-chlorophenyl)-5-methyl- |
0.0382675857669585 |
-0.28921923 |
NSC 711739 |
Null |
0.0382675857669585 |
-0.33689565 |
NSC 717708 |
Null |
0.0382675857669585 |
0.20501787 |
NSC 718185 |
Null |
0.0382675857669585 |
-0.033983651 |
NSC 727987 |
NSC 708783 incorporated in micelles, 0.20% (w/w) of drug |
0.0382675857669585 |
-0.063309297 |
NSC 740160 |
2-{4-[4-(5-morpholino-1H-benzo[d]imidazol-2-yl)phenoxy]butyl }-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione |
0.0382675857669585 |
-0.12645058 |
NSC 742799 |
3-amino-N-(4-benzylphenyl)-1H-indazole-1-carboxamide |
0.0382675857669585 |
-0.19034501 |
NSC 748900 |
[(20S)-20-(N,N-dimethylamino)-3a-(tigloylamino)-5a-preg-2a -O-acetate-4a-ol] |
0.0382675857669585 |
-0.16370161 |
NSC 123978 |
Sarveroside |
0.0382675857669588 |
0.0022670533 |
NSC 13317 |
Null |
0.0382675857669588 |
-0.34421162 |